Primary tumor in the craniovertebral junction
Conditions
Interventions
Experimental group:Use 3D Printed PEEK for One-Stage Cranial Base Reconstruction in Craniovertebral Junction Surgery.
Sponsors
Beijing Tiantan Hospital, Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Patients with primary tumors in the craniovertebral junction who have surgical indications; 2. Karnofsky Performance Status (KPS) score >= 60; 3. The subject or their guardian is able to understand the purpose of the trial, demonstrates sufficient compliance with the trial protocol, and signs the informed consent form. 4. Adults aged 18 years or older and under 70 years; 5. Patients who can undergo CT and MRI examinations.
Exclusion criteria
Exclusion criteria: 1. Patients with coagulation disorders or significant scarring tendencies; 2. Patients with contraindications to CT or MRI; 3. Pregnant or breastfeeding women, or those planning to become pregnant within 6 months; 4. Subjects who have participated in any other drug or medical device clinical trials within 3 months prior to screening; 5. Subjects who, in the investigator's judgment, have poor compliance, evidence of severe or uncontrolled systemic diseases, or are otherwise deemed unsuitable for participation in this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Degree of Bony and Soft Tissue Reduction of the Cranial Base; | — |
Secondary
| Measure | Time frame |
|---|---|
| incidence of epidural effusion;Pain; | — |
Countries
China
Contacts
Public ContactWang Jia
Beijing Tiantan Hospital, Capital Medical University
Outcome results
None listed